Jubilant Therapeutics Inc. to Present at Credit Suisse and Jefferies Investor Conferences
04 November 2022 | Friday | News
-Jubilant Therapeutics Inc., a clinical-stage biopharmaceutical company developing precision oral drugs with an improved therapeutic index for genetically defined patients with cancer and autoimmune diseases, today announced thatSyed Kazmi , Chief Executive Officer, will give a presentation on the current course of business and meet institutional investors at the following conferences in November 2022:
|
Event: |
Credit Suisse 31st Annual Health Conference, Ranchos Palos Verde, California |
|
Date: |
Monday, November 7 to Thursday, November 10, 2022 |
|
Participant: |
Syed Kazmi, Chief Executive Officer, Jubilant Therapeutics Inc. |
|
Time: |
2:35 p.m. to 3:05 p.m. PST (5:35 p.m. to 6:05 p.m. EST) on Wednesday,November 9 |
|
Event: |
Jefferies London Healthcare Conference, London |
|
Date: |
Tuesday, November 15 to Thursday, November 17 |
|
Participant: |
Syed Kazmi, Chief Executive Officer, Jubilant Therapeutics Inc. |
|
Time: |
8:35 a.m. GMT (3:35 a.m. EST) on Wednesday,November 16 |
Most Read
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
